197 related articles for article (PubMed ID: 37777587)
21. Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation.
Spillier Q; Vertommen D; Ravez S; Marteau R; Thémans Q; Corbet C; Feron O; Wouters J; Frédérick R
Sci Rep; 2019 Mar; 9(1):4737. PubMed ID: 30894617
[TBL] [Abstract][Full Text] [Related]
22. Supervised Disulfiram's Superior Effectiveness in Alcoholism Treatment: Ethical, Methodological, and Psychological Aspects.
Brewer C; Streel E; Skinner M
Alcohol Alcohol; 2017 Mar; 52(2):213-219. PubMed ID: 28064151
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram.
Malka F; Dairou J; Ragunathan N; Dupret JM; Rodrigues-Lima F
FEBS J; 2009 Sep; 276(17):4900-8. PubMed ID: 19664055
[TBL] [Abstract][Full Text] [Related]
24. [Disulfiram therapy].
Widenius T; Salaspuro M
Duodecim; 1994; 110(2):153-8. PubMed ID: 7555786
[No Abstract] [Full Text] [Related]
25. Tolerance to disulfiram induced by chronic alcohol intake in the rat.
Tampier L; Quintanilla ME; Israel Y
Alcohol Clin Exp Res; 2008 Jun; 32(6):937-41. PubMed ID: 18445101
[TBL] [Abstract][Full Text] [Related]
26. Experienced acetaldehyde reaction does not improve treatment response in outpatients treated with supervised disulfiram.
Mutschler J; Dirican G; Funke S; Obermann C; Grosshans M; Mann K; Kiefer F; Diehl A
Clin Neuropharmacol; 2011; 34(4):161-5. PubMed ID: 21677573
[TBL] [Abstract][Full Text] [Related]
27. Supervised disulfiram in the treatment of alcohol use disorder: a commentary.
Krampe H; Spies CD; Ehrenreich H
Alcohol Clin Exp Res; 2011 Oct; 35(10):1732-6. PubMed ID: 21569053
[TBL] [Abstract][Full Text] [Related]
28. FDA-approved disulfiram as a novel treatment for aggressive leukemia.
Karsa M; Xiao L; Ronca E; Bongers A; Spurling D; Karsa A; Cantilena S; Mariana A; Failes TW; Arndt GM; Cheung LC; Kotecha RS; Sutton R; Lock RB; Williams O; de Boer J; Haber M; Norris MD; Henderson MJ; Somers K
J Mol Med (Berl); 2024 Apr; 102(4):507-519. PubMed ID: 38349407
[TBL] [Abstract][Full Text] [Related]
29. Safety issues concerning the use of disulfiram in treating alcohol dependence.
Chick J
Drug Saf; 1999 May; 20(5):427-35. PubMed ID: 10348093
[TBL] [Abstract][Full Text] [Related]
30. Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.
Schroeder JP; Cooper DA; Schank JR; Lyle MA; Gaval-Cruz M; Ogbonmwan YE; Pozdeyev N; Freeman KG; Iuvone PM; Edwards GL; Holmes PV; Weinshenker D
Neuropsychopharmacology; 2010 Nov; 35(12):2440-9. PubMed ID: 20736996
[TBL] [Abstract][Full Text] [Related]
31. [Mechanism of action of disulfiram and treatment optimization in prevention of recurrent alcoholism].
Mutschler J; Kiefer F
Praxis (Bern 1994); 2013 Jan; 102(3):139-46. PubMed ID: 23384983
[TBL] [Abstract][Full Text] [Related]
32. Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis.
Burman WJ; Terra M; Breese P; Cohn D; Reves R
Int J Tuberc Lung Dis; 2002 Sep; 6(9):839-42. PubMed ID: 12234141
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial.
Carroll KM; Nich C; Shi JM; Eagan D; Ball SA
Drug Alcohol Depend; 2012 Nov; 126(1-2):224-31. PubMed ID: 22695473
[TBL] [Abstract][Full Text] [Related]
34. Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action.
Mutschler J; Diehl A; Kiefer F
J Clin Psychopharmacol; 2009 Feb; 29(1):99-101. PubMed ID: 19142124
[No Abstract] [Full Text] [Related]
35. Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety.
Mutschler J; Grosshans M; Koopmann A; Mann K; Kiefer F; Hermann D
Clin Neuropharmacol; 2010; 33(6):285-7. PubMed ID: 20975547
[TBL] [Abstract][Full Text] [Related]
36. [Psychosis during and after disulfiram use].
Verbon H; de Jong CA
Ned Tijdschr Geneeskd; 2002 Mar; 146(12):571-3. PubMed ID: 11938582
[TBL] [Abstract][Full Text] [Related]
37. Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway.
Majera D; Skrott Z; Chroma K; Merchut-Maya JM; Mistrik M; Bartek J
Cells; 2020 Feb; 9(2):. PubMed ID: 32085572
[TBL] [Abstract][Full Text] [Related]
38. Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.
Maremmani AG; Pani PP; Rovai L; Pacini M; Dell'Osso L; Maremmani I
Int J Environ Res Public Health; 2011 Jul; 8(7):2816-27. PubMed ID: 21845160
[TBL] [Abstract][Full Text] [Related]
39. The efficacy of disulfiram for the treatment of alcohol use disorder.
Jørgensen CH; Pedersen B; Tønnesen H
Alcohol Clin Exp Res; 2011 Oct; 35(10):1749-58. PubMed ID: 21615426
[TBL] [Abstract][Full Text] [Related]
40. Drug Repurposing as an Antitumor Agent: Disulfiram-Mediated Carbonic Anhydrase 12 and Anion Exchanger 2 Modulation to Inhibit Cancer Cell Migration.
Hwang S; Shin DM; Hong JH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31546841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
